Glossary

AJAX progress indicator
Search:
(clear)
  • CDSP
    Council of Health Ministers (CDSP) http://www.coe.int/t/dg3/health/CDSP_en.asp"
  • CIOMS
    Council for International Organisations of Medical Sciences (CIOMS) http://www.cioms.ch/"
  • CMDh
    Coordination Group for Mutual Recognition and Decentralised procedures – human (CMDh) http://www.hma.eu/cmdh.html"
  • Confounding Variable
    A confounding variable is something, other than the treatment being studied, that can affect the measured outcome of a trial . For example, imagine that a medicine to prevent the common cold is tested by administering it to 1,000 men, while a placebo is administered to a group of 1,000 women.(...)
  • Continuous endpoint
    A measurement, often expressed in numbers, collected in a clinical trial that represents a specific variable. Unlike binary endpoints which are expressed by ‘yes’ or ‘no’ (e.g. ‘survived’ against ‘dead’), continuous endpoints are expressed by measurement on a continuum of possible values over(...)
  • Contract research organisation
    A contract research organisation (CRO) is an independent organisation that provides support into the medicines development process. Typically, a CRO will organise and conduct clinical trials to test an investigational medicinal product in humans.
  • Coordination Group for Mutual Recognition and Decentralised procedures – human
    Coordination Group for Mutual Recognition and Decentralised procedures – human (CMDh) http://www.hma.eu/cmdh.html"
  • Cost effectiveness
    In the context of pharmacoeconomics, cost effectiveness is studied by looking at the results of different interventions by measuring a single outcome, usually in 'natural' units (for example, life-years gained, deaths avoided, heart attacks avoided, or cases detected).Alternative interventions(...)
  • Council for International Organisations of Medical Sciences
    Council for International Organisations of Medical Sciences (CIOMS) http://www.cioms.ch/"
  • Council of Health Ministers
    Council of Health Ministers (CDSP) http://www.coe.int/t/dg3/health/CDSP_en.asp"
  • Criteria for 'go/no-go' decisions
    Compounds under investigation as potential new medicines must meet certain criteria, at each stage of development, in order to progress further. These criteria need to be agreed upon by the medicines developers. A ‘go’ decision means that the compound meets the criteria, and will be advanced(...)
  • CRO
    A contract research organisation (CRO) is an independent organisation that provides support into the medicines development process. Typically, a CRO will organise and conduct clinical trials to test an investigational medicinal product in humans.
  • Cross-Sectional Study
    A cross-sectional study is one type of observational study, in which the researcher does not perform any intervention (such as administering a medicine).Cross-sectional studies are primarily used to find out how many cases of a disease are present in a population at a given point in time(...)
  • Danish Medicines Agency (Denmark)
    Danish National Competent Authority. http://laegemiddelstyrelsen.dk/en/"
  • DKMA
    Danish National Competent Authority. http://laegemiddelstyrelsen.dk/en/"

Find Out More